$1.04 (-2.80%)

Volume: 111.102k

Closed: Mar 24, 2023

Hollow Logo Score: -6.765
Assembly Biosciences Stock
$1.04 (-2.80%)

Volume: 111.102k

Closed: Mar 24, 2023

Score Hollow Logo -6.765
NASDAQ:ASMB

Assembly Biosciences Stock News

Assembly Biosciences Inc: Read more
INDIANAPOLIS and SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the t Read more
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, a Read more
INDIANAPOLIS and SAN FRANCISCO, April 02, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the t Read more
INDIANAPOLIS and SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the t Read more
On the other hand, Assembly Biosciences, Inc. by far traveled 243.23% versus a 1-year low price of $18.60. The share price was last seen 9.8% higher, reaching at $63.84 on Mar. 12, 2018.Related Symbol Read more
* ASSEMBLY BIOSCIENCES ANNOUNCES ADDITIONS TO MANAGEMENT TEAM AND BOARD OF DIRECTORS Read more
Assembly Biosciences Inc: Read more
INDIANAPOLIS, March 12, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepati Read more
INDIANAPOLIS, March 12, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepati Read more
Assembly Biosciences logo Victory Capital Management Inc. raised its stake in Assembly Biosciences Inc (NASDAQ:ASMB) by 54.1% during the fourth quarter, according to its most recent filing with the Se Read more
INDIANAPOLIS, March 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepati Read more
INDIANAPOLIS, March 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of ... Read more
Assembly Biosciences logo JPMorgan Chase & Co. grew its stake in shares of Assembly Biosciences Inc (NASDAQ:ASMB) by 6.9% in the 3rd quarter, according to its most recent filing with the Securitie Read more
The following slide deck was published by Assembly Biosciences, Inc. in conjunction with this event. Read more
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE